Argatroban and epistaxis Patient Reports February 13, 2012

Argatroban Side Effects Report #5430603-7
Argatroban side effect was reported by a Consumer or non-health professional from JAPAN on Aug 10, 2007. Female patient, 75 years of age, was diagnosed with heparin-induced thrombocytopenia and was treated with Argatroban. After drug was administered, patient experienced the following side effects: anaemia, cardiac failure, epistaxis, operative haemorrhage. Argatroban dosage: unknown. Patient recovered.

Argatroban Side Effects Report #5167063-X
Argatroban side effect was reported by a Pharmacist from UNITED STATES on Oct 23, 2003. Male patient, 54 years of age, weighting 208.3 lb, was diagnosed with continuous haemodiafiltration, heparin-induced thrombocytopenia and was treated with Argatroban. After drug was administered, patient experienced the following side effects: activated partial thromboplastin time prolonged, epistaxis, injection site haemorrhage, international normalised ratio increased, platelet count decreased. Argatroban dosage: unknown. During the same period patient was treated with ACTIVASE, LACTULOSE, LEVOFLOXACN, RABREPRAZOLE, SALMETEROL, ALBUTEROL. Patient recovered.

Argatroban Side Effects Report #5168179-4
Argatroban side effect was reported by a Pharmacist from UNITED STATES on July 25, 2003. Male patient, 70 years of age, was treated with Argatroban. After drug was administered, patient experienced the following side effects: activated partial thromboplastin time prolonged, coagulation factor increased, epistaxis, international normalised ratio increased, liver function test abnormal, prothrombin time prolonged. Argatroban dosage: 155 MG CONT IV. Patient recovered.